Roxithromycin is a semi-synthetic macrolide antibiotic. It is used to treat respiratory tract, urinary and soft tissue infections.
This report contains market size and forecasts of Roxithromycin in global, including the following market information:
Global Roxithromycin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Roxithromycin Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Roxithromycin companies in 2021 (%)
The global Roxithromycin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Roxithromycin Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Roxithromycin include Hetero Healthcare, Finecure Pharmaceuticals, Zhejiang Zhenyuan Pharmaceutical, Johnson & Johnson, Hygeia Laboratories, Bayer AG, Allergan, Galderma SA and Valeant Pharmaceutical International, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Roxithromycin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Roxithromycin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Roxithromycin Market Segment Percentages, by Type, 2021 (%)
Roxithromycin Tablets
Roxithromycin Capsules
Roxithromycin Granules
Global Roxithromycin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Roxithromycin Market Segment Percentages, by Application, 2021 (%)
Respiratory Tract Infections
Urinary Infections
Soft Tissue Infections
Global Roxithromycin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Roxithromycin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Roxithromycin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Roxithromycin revenues share in global market, 2021 (%)
Key companies Roxithromycin sales in global market, 2017-2022 (Estimated), (MT)
Key companies Roxithromycin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hetero Healthcare
Finecure Pharmaceuticals
Zhejiang Zhenyuan Pharmaceutical
Johnson & Johnson
Hygeia Laboratories
Bayer AG
Allergan
Galderma SA
Valeant Pharmaceutical International
Stiefel Laboratories
Cipher
Sigma-Aldrich
Hovione